Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UN Panel To Hear Stakeholder Ideas On IP, Innovation And Access

This article was originally published in Scrip

Executive Summary

Later this month, the UN high-level panel on access to medicines will hold public hearings to discuss the ideas it has received from stakeholders on how best to ensure access to affordable and high-quality drug treatment while continuing to encourage innovation and the development of new medicines, vaccines and diagnostics.

Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

SC064669

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel